Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. - Wikidata - wikimedia - TriplyDB

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

http://www.wikidata.org/entity/Q34872953

about

Ion Channels and Oxidative Stress as a Potential Link for the Diagnosis or Treatment of Liver Diseases Inflammatory status in human hepatic cirrhosis Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1 Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice miR-217 regulates ethanol-induced hepatic inflammation by disrupting sirtuin 1-lipin-1 signaling.Efficiency of double layered microencapsulated probiotic to modulate proinflammatory molecular markers for the management of alcoholic liver disease.Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis.The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes EOLA1 protects lipopolysaccharide induced IL-6 production and apoptosis by regulation of MT2A in human umbilical vein endothelial cells.Wild bitter gourd protects against alcoholic fatty liver in mice by attenuating oxidative stress and inflammatory responses.Effects of ceftriaxone on systemic and central expression of anti- and pro-inflammatory cytokines in alcohol-preferring (P) rats exposed to ethanol.The peritoneal macrophage inflammatory profile in cirrhosis depends on the alcoholic or hepatitis C viral etiology and is related to ERK phosphorylation.Alterations of the gut microbiome and metabolome in alcoholic liver disease Role of IRAK-M in alcohol induced liver injury.Pathogenesis of alcoholic liver disease: role of oxidative metabolism.Chronic alcohol consumption enhances iNKT cell maturation and activation Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.15th International Symposium on Cells of the Hepatic Sinusoid, 2010.Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related Differences β-catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice.Acute ethanol gavage attenuates hemorrhage/resuscitation-induced hepatic oxidative stress in rats.Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease.Structural Correlates of PPAR Agonist Rescue of Experimental Chronic Alcohol-Induced Steatohepatitis Altered expression of cytokine signaling pathway genes in peripheral blood cells of alcohol dependent subjects: preliminary findings.Cell signals influencing hepatic fibrosis New Approaches for Studying Alcoholic Liver Disease Original inhibition method of excessive synthesis of pro-inflammatory cytokine of tumour necrosis factor α.Rodent models of alcoholic liver disease: of mice and men.Fibromyalgia symptoms and cirrhosis.Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis.Adipose tissue-liver axis in alcoholic liver disease.Barley Sprouts Extract Attenuates Alcoholic Fatty Liver Injury in Mice by Reducing Inflammatory Response Tobacco Smoke-Induced Hepatic Injury with Steatosis, Inflammation, and Impairments in Insulin and Insulin-Like Growth Factor Signaling.Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences.Role of adaptive immunity in alcoholic liver disease.Molecular basis of alcoholic fatty liver disease: From incidence to treatment.

P2860

Q26765808-238E1F37-058B-44AB-9A16-301B95FAADEE Q26778040-28359CFB-A657-4EA2-808B-2B913028A3B2 Q26799149-9EAF816E-9C7E-4B0E-A771-9682D86F0FCA Q26801150-B776C29A-C0EC-44C5-8D4F-663862837FF2 Q27026399-B52398CC-5F05-4CA3-BAB2-D79550204553 Q28240106-0E10C467-7B1E-4CEF-85A3-57E0EF8A551F Q30359251-8CC1433C-5D83-45C3-8733-C08250F10DFB Q33748252-6E6B869C-77A0-461D-B473-049CD2B68588 Q33826344-140582F5-AEAE-49A0-8C61-75A0F6DCCE14 Q33997351-3DCECAE4-A980-42BD-9238-BE15E73FDA13 Q33997607-C462529C-DA85-492B-B5D9-AA24A028C646 Q34038218-2DBF5ECA-80B7-493E-90BF-4F3BBA8D44BF Q34040303-48243C35-676B-4554-B072-52D9DF4388E6 Q34048165-BD1F9426-4045-45ED-A1CC-9DDD89C57007 Q34367509-9911B491-6A8F-4E69-AD10-D6C88889B8B3 Q34508873-F57C51A5-6A47-478D-9771-A22D3CCF3F46 Q34600023-A5C6B703-9C36-43C3-BCBE-B1D9871D504F Q34750539-FF27FE86-77EA-486D-AA93-C8B132D782D7 Q34987153-06709B30-F536-4A1E-BDAE-4C8486C6EEE6 Q35081538-63FAC352-9915-417C-B463-45436FAE087C Q35209239-D50A0B96-69FC-4D78-AC55-35C565DE0C3F Q35299560-519DD627-4393-49D4-AF04-5C19BB0FD1BA Q35673289-605C93DC-0184-4381-BA04-B44D8F9AAAD6 Q35783512-80DD96A7-E237-4CD2-858F-B8E41DBEAE1D Q35893579-982C23D9-6F82-4E6F-98CE-F8E119A85277 Q35944938-B6AFC5CF-6B04-436E-AF08-866EADB37D2F Q36011202-6C1C5584-34A9-4DC4-85F6-340C13C0AA5E Q36087235-3904A9D3-0BA7-4931-985F-608F186136B0 Q36220879-BA7875F5-61ED-4458-B91C-874D9ECC7C35 Q36288405-0821A2C2-6292-4AD2-87F7-195776D13F16 Q36305630-E228E2B5-3E08-4032-A1D8-D2B4F6AD85EF Q36395131-A00F4A4A-CFC7-4265-9868-23681FFED959 Q36396701-FCA6F52F-370C-4FBD-A494-1B92520A0D81 Q36469896-8630B4E9-0EE5-4262-847F-C5672E96DEE7 Q36578908-F247D1E3-5FC2-4202-AD8C-58BAB315888B Q37133129-FA0A27E7-DC0C-43BF-874E-2D539355CB82 Q37164479-1CE65A3C-0E37-4E27-83B4-741B93A3817B Q37635136-1EC8D701-18A3-4F72-A028-9F05C51E1B66 Q38333417-041D45F7-1234-4AF8-8E69-FD1FDF12FB35 Q38595071-FE6DD71C-D4A8-4EFC-8E00-8C03D511B89A

P2860

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

http://www.wikidata.org/entity/Q34872953

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

@ast

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

@en

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

@nl

type

label

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

@ast

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

@en

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

@nl

prefLabel

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

@ast

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

@en

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

@nl

P1433

Q34872953-559CA7E0-B87B-41DA-91CA-785169058CC6

P1476

Q34872953-BC55DBB0-6C3A-4C41-A1DC-687D1190BBA5

P2093

Q34872953-01BB42CC-7D22-4A4E-BEB6-C70EB597E180

Q34872953-3C16824B-DD32-4D61-8BA3-272FDED115DC

Q34872953-4028DAC0-84E6-4950-8146-E283334871D7

Q34872953-48BC1A48-EBAF-45E8-A20B-6564CCF7CD24

Q34872953-C5AACFFA-448D-4041-A7AD-AB283C70F39C

P2860

Q34872953-00BB6591-B3C0-40E0-9D84-B6ECF3D41FC3

Q34872953-088B44AA-9ABC-4423-97BD-A9008C9E5753

Q34872953-0AB96E8F-CFA8-46E8-A89D-71D4257DCAF6

Q34872953-1C263399-9F91-42B2-BB99-7FBCCFCACCDE

Q34872953-1E94DF32-C2E8-4D6D-9E7F-56AD5CD2AB41

Q34872953-20E41DC8-629B-40FF-8C17-00F288423023

Q34872953-235C284B-37AC-453D-86C2-2230889E753C

Q34872953-264C15D5-55FF-4AD2-9379-1161B48BD428

Q34872953-27E5AA0C-2E48-4AA9-93C4-A66A83B4903D

Q34872953-291545DC-3F6F-4129-8BA7-1FA9E98F6BD1

P304

Q34872953-86B556FA-BEF9-4CA8-87C1-D1F7B877EFD5

P31

Q34872953-84297183-6059-4FE3-9820-5328F91EA324

P356

Q34872953-6A23B320-5777-4DA8-91AA-3C8F0292E6A9

P433

Q34872953-B95E7B35-EA31-4685-8AA5-C85A5EEA4A66

P478

Q34872953-5CEAD617-86DB-4214-AE04-990B745DA529

P577

Q34872953-2EA6CD82-9009-41B9-9AA9-068214B40D94

P5875

Q34872953-29BB7351-C0B2-4BC3-B027-43694218AEAC

P698

Q34872953-68EBBF51-D6A6-4BA3-AE6A-27BAA6FFCDA9

P932

Q34872953-A5DD5765-8227-41EE-9C58-61F825E478A9

P356

J.1530-0277.2010.01399.X

P1433

Alcoholism: Clinical and Experimental Research

P1476

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

@en

P2093

Andrew M Miller

http://www.w3.org/2001/XMLSchema#string

Bin Gao

http://www.w3.org/2001/XMLSchema#string

Norio Horiguchi

http://www.w3.org/2001/XMLSchema#string

Svetlana Radaeva

http://www.w3.org/2001/XMLSchema#string

Won-Il Jeong

http://www.w3.org/2001/XMLSchema#string

P2860

Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway

Senescence of activated stellate cells limits liver fibrosis

Interleukin-10: new perspectives on an old cytokine

TLR4 enhances TGF-beta signaling and hepatic fibrosis

In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats.

Natural killer group 2 member D, its ligands, and liver disease: good or bad?

Interplay of hepatic and myeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity.

Anti-inflammatory and anti-apoptotic roles of endothelial cell STAT3 in alcoholic liver injury

Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

P304

787-793

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1530-0277.2010.01399.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49801597

http://www.w3.org/2001/XMLSchema#string

P698

21284667

http://www.w3.org/2001/XMLSchema#string

P932

3083482

http://www.w3.org/2001/XMLSchema#string